GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudarshan Pharma Industries Ltd

Sudarshan Pharma Plans Fundraise via Board Meeting on June 18, 2026

FUNDRAISE ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 15 Jun 2026, 07:21 PM IST  ·  BSE ID: ba7fe412-b806-4c88-a8fe-397e34fc5eac
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will discuss and potentially approve a plan to raise more money through selling shares or other financial instruments.
🤖 AI Summary
  • Sudarshan Pharma board to meet June 18, 2026, to consider fund raising.
  • Proposal includes equity shares, convertible securities, warrants, or debt securities.
  • Fundraising methods to be considered are Private Placement or QIP.
  • Company will approve necessary ancillary actions for the fundraising plan.
🏢 How This Affects the Company
📈
Business Impact
The company is actively seeking capital, which could fund expansion, acquisitions, or debt repayment, impacting future business growth opportunities.
💰
Financial Impact
Fundraising will alter the company's capital structure, potentially increasing equity or debt. This aims to strengthen its financial position for strategic initiatives.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders. Monitor future announcements regarding the fund raising plan.
👤
Who Is Affected
All shareholders will be affected by potential dilution if equity or convertible securities are issued. Debt issuance will impact leverage ratios.
🔍
Management Signal
This signals management's intent to secure additional capital for strategic growth or financial flexibility.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on June 18, 2026, for fund raising details.
Details of instruments to be issued and fundraising method.
Announcement of specific fund raising amount and terms.
MEDIUM RISK Potential for share dilution or increased leverage depending on fund raising method.
💡 Investor Takeaway
Sudarshan Pharma Industries Ltd board will convene on June 18, 2026, to evaluate and approve a proposal for raising capital through various instruments including equity, warrants, or debt via private placement or QIP.
⚖️ Strengths & Concerns

✅ Positives

  • Board meeting scheduled to consider strategic fund raising options.
  • Previous capital infusion via warrants on June 12, 2026, indicates proactive capital management.
❓ Frequently Asked Questions
When is the Sudarshan Pharma Industries Ltd board meeting scheduled?
The meeting of the Board of Directors of Sudarshan Pharma Industries Ltd is scheduled for Thursday, June 18, 2026.
What is the primary agenda for Sudarshan Pharma's board meeting on June 18, 2026?
The primary agenda is to consider and approve a proposal for raising funds through various financial instruments.
What methods might Sudarshan Pharma use for fundraising?
The company may raise funds via Private Placement, Preferential Issue, Qualified Institutional Placement, or other methods using equity shares, convertible securities, warrants, or debt securities.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.